Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer

NCT04518501 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Efficacy and Safety

Interventions

DRUG: Arsenic trioxide Tablet +Fuzuloparib Capsules

Sponsor

Xing Xie